Article

Outcome myasthenia gravis patients with Covid-19

2022-03-17

Abstract excerpt

<h4>Background: </h4> Previous data about myasthenia gravis (MG) patients with Covid-19 are sporadic and insufficient to make any conclusion how they affect each other. Therefore, we present our experience with a group of MG patients who were infected with Covid-19. Cases presentation We present clinical outcome in 13 patients with generalized autoimmune MG and COVID-19. Patients were divided into two groups depen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5229dcfb-f292-5766-b0a4-d72533ce25a9
DOI: 10.21203/rs.3.rs-1455897/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Outcome myasthenia gravis patients with Covid-19DOI 10.21203/rs.3.rs-1455897/v1Read

The impact of COVID-19 epidemic on adult Myasthenia Gravis patientsSemantic proximity Read

Clinical characteristics and outcome of treatment-refractory myasthenia gravis -a retrospective studySemantic proximity Read

A Retrospective Longitudinal Cohort Study of The Clinical Burden in Myasthenia GravisSemantic proximity Read

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read

Dropped Head Syndrome in Myasthenia Gravis After a SARS‐CoV‐2 Infection: Case ReportSemantic proximity Read

Real-World Case Series of Efgartigimod for Generalized Myasthenia Gravis：Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom ControlSemantic proximity Read

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesSemantic proximity Read

Epilepsy and Myasthenia Gravis, a Case SeriesSemantic proximity Read

Efgartigimod efficacy and safety in refractory Myasthenia Gravis - UK’s first real-world experienceSemantic proximity Read

Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell TherapySemantic proximity Read

Early Versus Delayed Add-on Therapy in Generalized Myasthenia Gravis: A Multicenter Real-World Cohort StudySemantic proximity Read

Study of the prevalence of familial autoimmune myasthenia gravis in a Spanish cohort.Semantic proximity Read